Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Dayforce, Thoma Bravo

The Wall Street Journal on MSN · 2d
Thoma Bravo to Buy Dayforce for $11.2 Billion
Dayforce has agreed to be acquired by private-equity firm Thoma Bravo in a deal that values the provider of human-resources software at around $11.2 billion.
Reuters on MSN · 2d
Dayforce to go private in $12.3 billion Thoma Bravo acquisition
Private equity firm Thoma Bravo has agreed to buy human resources software provider Dayforce for $12.3 billion, including debt, in a take-private deal that executives hope will help expand on the company's AI capabilities.
MarketWatch on MSN · 2d
Dayforce’s stock wasn’t getting enough love, so Thoma Bravo stepped in with $12 billion
The $12 billion take-private deal of the human-resources software company comes after the stock had already lost more than a quarter of its value this year.
5d

Private Equity Powerhouse Eyes Dayforce in Billion-Dollar Deal

Private equity giant Thoma Bravo is reportedly circling Dayforce, a $1.76B cloud HCM leader, in what could be a landmark deal ...
2don MSN

Goldman Sachs pledges $6B debt package for Thoma Bravo's Dayforce takeover - report

Goldman Sachs (NYSE:GS) has lined up a $6B debt financing package to back private equity firm Thoma Bravo's acquisition of HR ...
5don MSN

A buyout firm reportedly has Dayforce in its sights. Shares of the HR software group are soaring.

Buyout firm Thoma Bravo could announce a deal in the next few weeks to take Dayforce private, Bloomberg reported on Monday, citing sources.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy